• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骶骨脊索瘤的外科治疗:生存率及预后因素

Surgical treatment of sacral chordoma: survival and prognostic factors.

作者信息

Ruosi C, Colella G, Di Donato S L, Granata F, Di Salvatore M G, Fazioli F

机构信息

Orthopaedic Section, Public Health Department, University of Naples "Federico II", Via S. Pansini 5, 80131, Naples, Italy.

Division of Skeletal Muscle Oncology Surgery, National Cancer Institute G. Pascale Foundation, IRCCS, Naples, Italy.

出版信息

Eur Spine J. 2015 Nov;24 Suppl 7:912-7. doi: 10.1007/s00586-015-4276-4. Epub 2015 Oct 12.

DOI:10.1007/s00586-015-4276-4
PMID:26458933
Abstract

INTRODUCTION

Sacral chordoma is a rare low-to-intermediate grade malignant tumour. The mainstay of treatment is still surgery with en bloc and wide resection margins, which can grant the best chances of a long-term control or cure of this disease. The first aim of this paper is to collect data about survival, time to local recurrence and metastasis among patients affected by sacral chordoma and primarily treated with surgery. The second aim is to analyze the influence of level resection, tumor volume and surgical margins on local recurrence.

MATERIALS AND METHODS

The study population was composed of 14 patients treated with sacral chordoma resection at the National Tumour Institute of Naples-Pascale (Italy) from January 2000 to June 2013. The median follow-up was 84 months (range 24-132 months). The follow-up was characterized by: standard radiographs, MRI, and a CT scan of the chest annually. Time to recurrence or metastasis was calculated from the date of resection to the date of diagnosis of first recurrence or metastasis.

RESULTS

Out of all the patients, six died (42.86 %) during the follow-up; 6 (42.86 %) had local recurrence; 4 (28.57 %) had metastasis. At univariate analysis wide surgical margins (R0) were associated with increased survival up to a local recurrence (OR = 0.0286; 95 % CI = 0.0014-0.5739; P = 0.026); the level of resection (OR = 3.33; 95 % CI = 0.3619-30.7025; P = 0.592) and tumour volume (P = 1) did not show a statistically significant correlation.

DISCUSSION

Based on our experience, we hope all patients to be treated by surgery, the only good standard treatment of this disease. The resection should result in margins as wide as possible. For these reasons, it is essential for this disease to be treated in highly specialized centres because only a complete surgery can offer a chance to care for these patients.

CONCLUSIONS

Solid survival at long-term follow-up can be achieved by a surgical resection performed with wide margins.

摘要

引言

骶骨脊索瘤是一种罕见的低至中等级别恶性肿瘤。治疗的主要手段仍然是整块切除且切除边缘足够宽的手术,这能为长期控制或治愈该疾病提供最佳机会。本文的首要目的是收集主要接受手术治疗的骶骨脊索瘤患者的生存情况、局部复发时间和转移情况的数据。第二个目的是分析切除水平、肿瘤体积和手术切缘对局部复发的影响。

材料与方法

研究人群包括2000年1月至2013年6月在意大利那不勒斯-帕斯卡莱国家肿瘤研究所接受骶骨脊索瘤切除术的14例患者。中位随访时间为84个月(范围24 - 132个月)。随访包括:每年进行标准X线片、MRI和胸部CT扫描。复发或转移时间从切除日期计算至首次复发或转移诊断日期。

结果

在所有患者中,6例(42.86%)在随访期间死亡;6例(42.86%)出现局部复发;4例(28.57%)发生转移。单因素分析显示,广泛的手术切缘(R0)与至局部复发的生存率提高相关(OR = 0.0286;95% CI = 0.0014 - 0.5739;P = 0.026);切除水平(OR = 3.33;95% CI = 0.3619 - 30.7025;P = 0.592)和肿瘤体积(P = 1)未显示出统计学显著相关性。

讨论

基于我们的经验,我们希望所有患者都接受手术治疗,这是该疾病唯一良好的标准治疗方法。切除应尽可能获得宽切缘。因此,这种疾病在高度专业化的中心进行治疗至关重要,因为只有完整的手术才能为治疗这些患者提供机会。

结论

通过进行宽切缘的手术切除可实现长期随访时的稳固生存。

相似文献

1
Surgical treatment of sacral chordoma: survival and prognostic factors.骶骨脊索瘤的外科治疗:生存率及预后因素
Eur Spine J. 2015 Nov;24 Suppl 7:912-7. doi: 10.1007/s00586-015-4276-4. Epub 2015 Oct 12.
2
Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.骶骨脊索瘤的外科治疗:切缘阴性的整块切除是长期预后的决定因素。
Surg Technol Int. 2018 Nov 11;33:343-348.
3
Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute.单机构171例骶骨脊索瘤的复发及生存因素分析
Eur Spine J. 2017 Jul;26(7):1910-1916. doi: 10.1007/s00586-016-4906-5. Epub 2016 Dec 9.
4
What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?115例骶骨脊索瘤患者接受手术治疗后的条件生存和功能结果如何?
Clin Orthop Relat Res. 2017 Mar;475(3):620-630. doi: 10.1007/s11999-016-4773-8.
5
Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.脊柱和骶骨的脊索瘤:对在两个转诊中心接受手术治疗的一系列患者的回顾性分析。
Ann Surg Oncol. 2010 Jan;17(1):211-9. doi: 10.1245/s10434-009-0740-x. Epub 2009 Oct 22.
6
Oncologic and functional outcome following sacrectomy for sacral chordoma.骶骨脊索瘤切除术后的肿瘤学和功能结局
J Bone Joint Surg Am. 2006 Jul;88(7):1532-9. doi: 10.2106/JBJS.D.02533.
7
Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.骶骨脊索瘤和软骨肉瘤整块切除后的长期临床结果:连续20例患者系列研究
Spine (Phila Pa 1976). 2009 Sep 15;34(20):2233-9. doi: 10.1097/BRS.0b013e3181b61b90.
8
A review of the surgical management of sacral chordoma.骶骨脊索瘤的外科治疗综述
Eur J Surg Oncol. 2014 Nov;40(11):1412-20. doi: 10.1016/j.ejso.2014.04.008. Epub 2014 Apr 25.
9
Role of intraoperative radiotherapy in the treatment of sacral chordoma.术中放疗在骶骨脊索瘤治疗中的作用。
Spine J. 2018 Apr;18(4):632-638. doi: 10.1016/j.spinee.2017.08.255. Epub 2017 Sep 4.
10
Surgical margins and local control in resection of sacral chordomas.骶骨脊索瘤切除术中的手术切缘和局部控制。
Clin Orthop Relat Res. 2010 Nov;468(11):2939-47. doi: 10.1007/s11999-010-1472-8.

引用本文的文献

1
Nomograms to predict lung metastasis in malignant primary osseous spinal neoplasms and cancer-specific survival in lung metastasis subgroup.预测原发性恶性脊柱骨肿瘤肺转移及肺转移亚组癌症特异性生存率的列线图。
Front Oncol. 2024 Aug 20;14:1393990. doi: 10.3389/fonc.2024.1393990. eCollection 2024.
2
Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review.接受骶骨切除术的原发性骨肿瘤患者的发病率和死亡率分析:一项系统综述。
J Bone Oncol. 2022 Jul 16;35:100445. doi: 10.1016/j.jbo.2022.100445. eCollection 2022 Aug.
3
LncRNA NONHSAT114552 Sponges miR-320d to Promote Proliferation and Invasion of Chordoma Through Upregulating NRP1.

本文引用的文献

1
Prognostic factors in surgical resection of sacral chordoma.骶骨脊索瘤手术切除的预后因素
J Surg Oncol. 2015 Sep;112(4):344-51. doi: 10.1002/jso.23987. Epub 2015 Aug 4.
2
Prognostic Factors in the Operative Management of Sacral Chordomas.骶骨脊索瘤手术治疗中的预后因素
World Neurosurg. 2015 Nov;84(5):1354-61. doi: 10.1016/j.wneu.2015.06.030. Epub 2015 Jun 23.
3
Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.骶骨脊索瘤的外科治疗:局部复发和总生存的预后变量
长链非编码RNA NONHSAT114552通过上调神经纤毛蛋白1(NRP1),作为微小RNA-320d的海绵吸附分子以促进脊索瘤的增殖和侵袭。
Front Pharmacol. 2021 Oct 13;12:773918. doi: 10.3389/fphar.2021.773918. eCollection 2021.
4
Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients With Long-Term Follow-Up.骶骨脊索瘤手术结果及并发症的影响:50例连续患者的长期随访报告
Global Spine J. 2021 Jun;11(5):740-750. doi: 10.1177/21925682211011444.
5
Cervical chordomas: multicenter case series and meta-analysis.颈椎脊索瘤:多中心病例系列和荟萃分析。
J Neurooncol. 2021 May;153(1):65-77. doi: 10.1007/s11060-021-03742-6. Epub 2021 Apr 3.
6
A case-control study of computer navigation assisted resection of primary sacral chordoma above sacrum 3 level.一项关于计算机导航辅助切除骶3水平以上原发性骶骨脊索瘤的病例对照研究。
J Bone Oncol. 2020 Jun 20;23:100303. doi: 10.1016/j.jbo.2020.100303. eCollection 2020 Aug.
7
Conditional survival and changing risk profile in patients with chordoma: a population-based longitudinal cohort study.脊索瘤患者的条件生存和风险特征变化:一项基于人群的纵向队列研究。
J Orthop Surg Res. 2019 Jun 17;14(1):181. doi: 10.1186/s13018-019-1225-7.
8
Defining preoperative imaging findings of sacral chordomas associated with decreased overall survival and local recurrence.确定与总生存率降低和局部复发相关的骶骨脊索瘤的术前影像学表现。
J Spine Surg. 2019 Mar;5(1):171-173. doi: 10.21037/jss.2019.03.04.
9
Adjuvant gamma knife surgery and image-guided, intensity-modulated radiation therapy for the treatment of sacral chordomas.辅助性伽玛刀手术及影像引导下的调强放射治疗用于骶骨脊索瘤的治疗
Rep Pract Oncol Radiother. 2019 Jan-Feb;24(1):74-79. doi: 10.1016/j.rpor.2018.10.007. Epub 2018 Nov 22.
10
Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features.基于 3D 计算机断层扫描特征的放射组学机器学习分类器和特征选择在区分骶骨脊索瘤和骶骨巨细胞瘤中的比较。
Eur Radiol. 2019 Apr;29(4):1841-1847. doi: 10.1007/s00330-018-5730-6. Epub 2018 Oct 2.
Eur Spine J. 2015 May;24(5):1092-101. doi: 10.1007/s00586-014-3728-6. Epub 2014 Dec 23.
4
A review of the surgical management of sacral chordoma.骶骨脊索瘤的外科治疗综述
Eur J Surg Oncol. 2014 Nov;40(11):1412-20. doi: 10.1016/j.ejso.2014.04.008. Epub 2014 Apr 25.
5
"En bloc" resection of sacral chordomas by combined anterior and posterior surgical approach: a monocentric retrospective review about 29 cases.采用前后联合手术入路“整块”切除骶骨脊索瘤:一项关于29例病例的单中心回顾性研究
Eur Spine J. 2014 Sep;23(9):1940-8. doi: 10.1007/s00586-014-3196-z. Epub 2014 Jan 28.
6
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
7
Chordoma: the nonsarcoma primary bone tumor.脊索瘤:非肉瘤性原发性骨肿瘤。
Oncologist. 2007 Nov;12(11):1344-50. doi: 10.1634/theoncologist.12-11-1344.
8
Oncologic and functional outcome following sacrectomy for sacral chordoma.骶骨脊索瘤切除术后的肿瘤学和功能结局
J Bone Joint Surg Am. 2006 Jul;88(7):1532-9. doi: 10.2106/JBJS.D.02533.
9
Chordoma of the mobile spine: fifty years of experience.活动脊柱脊索瘤:五十年的经验
Spine (Phila Pa 1976). 2006 Feb 15;31(4):493-503. doi: 10.1097/01.brs.0000200038.30869.27.
10
Operative management of sacral chordoma.骶骨脊索瘤的手术治疗
J Bone Joint Surg Am. 2005 Oct;87(10):2211-6. doi: 10.2106/JBJS.D.02693.